📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Engage Therapeutics

1.1 - Company Overview

Engage Therapeutics Logo

Engage Therapeutics

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of clinical-stage biopharmaceutical R&D focused on epilepsy, developing Staccato alprazolam, a small, easy-to-use hand-held drug-device combination that leverages an FDA-approved delivery system with FDA-approved alprazolam.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Engage Therapeutics

Exonics Therapeutics Logo

Exonics Therapeutics

HQ: United States Website
  • Description: Provider of biotechnology research leveraging adeno-associated virus (AAV) to deliver CRISPR/Cas9 payloads that identify and correct exon mutations preventing dystrophin production, a protein that helps stabilize and protect muscle fibers.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Exonics Therapeutics company profile →
Orphazyme Logo

Orphazyme

HQ: Denmark Website
  • Description: Provider of biopharmaceutical R&D for novel therapeutics targeting lysosomal storage diseases and other genetic disorders; conducts clinical trials, offers early access programs for investigational drugs, and delivers safety reporting/pharmacovigilance. Developed arimoclomol for neurodegenerative diseases, including Niemann Pick disease type C (sold to KemPharm Denmark A/S).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Orphazyme company profile →
Soligenix Logo

Soligenix

HQ: United States Website
  • Description: Provider of vaccines and therapeutics for biodefense and rare diseases, including HyBryte photodynamic therapy for cutaneous T-cell lymphoma; SGX302 light therapy for psoriasis; SGX942 IV dusquetide for severe oral mucositis in cancer patients; RiVax in-development ricin vaccine using ThermoVax thermal stabilization; and SGX943 dusquetide to reduce inflammation, eliminate infection, and enhance tissue healing in infectious diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Soligenix company profile →
Edgewise Therapeutics Logo

Edgewise Therapeutics

HQ: United States Website
  • Description: Provider of clinical-stage biopharmaceutical development of small-molecule therapies, including EDG-5506 to protect muscle fibers in rare skeletal muscle disorders (Duchenne and Becker muscular dystrophies), and EDG-7500, an oral, selective cardiac sarcomere modulator for hypertrophic cardiomyopathy and other diseases of cardiac diastolic dysfunction.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Edgewise Therapeutics company profile →
Cancer Prevention Pharmaceuticals Logo

Cancer Prevention Pharmaceuticals

HQ: United States Website
  • Description: Provider of pharmaceutical agents and prevention therapies for people at elevated risk of cancer in the United States. Offers difluoro-methyl ornithine for clinical cancer prevention and treatment trials and develops diagnostic methods.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Cancer Prevention Pharmaceuticals company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Engage Therapeutics

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Engage Therapeutics

2.2 - Growth funds investing in similar companies to Engage Therapeutics

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Engage Therapeutics

4.2 - Public trading comparable groups for Engage Therapeutics

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Engage Therapeutics

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Engage Therapeutics

What does Engage Therapeutics do?

Engage Therapeutics is a provider of clinical-stage biopharmaceutical R&D focused on epilepsy, developing Staccato alprazolam, a small, easy-to-use hand-held drug-device combination that leverages an FDA-approved delivery system with FDA-approved alprazolam.

Who are Engage Therapeutics's competitors?

Engage Therapeutics's competitors and similar companies include Exonics Therapeutics, Orphazyme, Soligenix, Edgewise Therapeutics, and Cancer Prevention Pharmaceuticals.

Where is Engage Therapeutics headquartered?

Engage Therapeutics is headquartered in United States.

How many employees does Engage Therapeutics have?

Engage Therapeutics has 1,000 employees 🔒.

When was Engage Therapeutics founded?

Engage Therapeutics was founded in 2010 🔒.

What sector and industry vertical is Engage Therapeutics in?

Engage Therapeutics is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Engage Therapeutics

Who are the top strategic acquirers in Engage Therapeutics's sector and industry

Top strategic M&A buyers and acquirers in Engage Therapeutics's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Engage Therapeutics?

Top strategic M&A buyers groups and sectors for Engage Therapeutics include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Engage Therapeutics's sector and industry vertical

Which are the top PE firms investing in Engage Therapeutics's sector and industry vertical?

Top PE firms investing in Engage Therapeutics's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Engage Therapeutics's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Engage Therapeutics's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Engage Therapeutics's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Engage Therapeutics include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Engage Therapeutics's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Engage Therapeutics?

The key public trading comparables and valuation benchmarks for Engage Therapeutics include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Engage Therapeutics for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Engage Therapeutics with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Engage Therapeutics's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Engage Therapeutics with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Engage Therapeutics's' sector and industry vertical?

Access recent funding rounds and capital raises in Engage Therapeutics's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Engage Therapeutics